Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 163

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes

Tabariès, S, Dong, Z, Annis, M G, Omeroglu, A, Pepin, F, Ouellet, V, Russo, C, Hassanain, M, Metrakos, P, Diaz, Z, Basik, M, Bertos, N, Park, M, Guettier, C, Adam, R, Hallett, M, Siegel, P M·2011·Oncogene

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2010.518

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 62

  1. Aung PP, Mitani Y, Sanada Y, Nakayama H, Matsusaki K, Yasui W . (2006). Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Virchows Arch 448: 428–434. · doi:10.1007/s00428-005-0120-2
  2. Berditchevski F, Odintsova E . (1999). Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J Cell Biol 146: 477–492. · DOI · Paper page
  3. Berditchevski F, Odintsova E, Sawada S, Gilbert E . (2002). Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling. J Biol Chem 277: 36991–37000. · DOI · Paper page
  4. Berkowitz N, Gupta S, Silberman G . (2000). Estimates of the lifetime direct costs of treatment for metastatic breast cancer. Value Health 3: 23–30. · DOI
  5. Blanchard AA, Skliris GP, Watson PH, Murphy LC, Penner C, Tomes L et al. (2009). Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch 454: 647–656. · doi:10.1007/s00428-009-0770-6
  6. Braet F, Riches J, Geerts W, Jahn KA, Wisse E, Frederik P . (2009). Three-dimensional organization of fenestrae labyrinths in liver sinusoidal endothelial cells. Liver Int 29: 603–613. · DOI
  7. Braet F, Wisse E . (2002). Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol 1: 1. · DOI · Paper page
  8. Buchert M, Papin M, Bonnans C, Darido C, Raye WS, Garambois V et al. (2010). Symplekin promotes tumorigenicity by up-regulating claudin-2 expression. Proc Natl Acad Sci USA 107: 2628–2633. · DOI
  9. Clark GM, Sledge Jr GW, Osborne CK, McGuire WL . (1987). Survival from first recurrence: relative importance of prognostic factors in 1015 breast cancer patients. J Clin Oncol 5: 55–61. · DOI · Paper page
  10. Creighton CJ, Chang JC, Rosen JM . (2010). Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 15: 253–260. · DOI · Paper page
  11. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A . et al. (2009). Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 106: 13820–13825. · DOI · Paper page
  12. Diamond JR, Finlayson CA, Borges VF . (2009). Hepatic complications of breast cancer. Lancet Oncol 10: 615–621. · DOI
  13. Eichbaum MH, Kaltwasser M, Bruckner T, de Rossi TM, Schneeweiss A, Sohn C . (2006). Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res Treat 96: 53–62. · DOI
  14. Enns A, Gassmann P, Schluter K, Korb T, Spiegel HU, Senninger N et al. (2004). Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J Gastrointest Surg 8: 1049–1059, discussion 1060. · doi:10.1016/j.gassur.2004.08.016
  15. Er O, Frye DK, Kau SW, Broglio K, Valero V, Hortobagyi GN et al. (2008). Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy. Cancer J 14: 62–68. · DOI
  16. Erin N, Wang N, Xin P, Bui V, Weisz J, Barkan GA et al. (2009). Altered gene expression in breast cancer liver metastases. Int J Cancer 124: 1503–1516. · DOI
  17. Fidler IJ . (1986). Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 5: 29–49. · DOI · Paper page
  18. Friedrichs J, Manninen A, Muller DJ, Helenius J . (2008). Galectin-3 regulates integrin alpha2beta1-mediated adhesion to collagen-I and -IV. J Biol Chem 283: 32264–32272. · DOI
  19. Giavazzi R, Jessup JM, Campbell DE, Walker SM, Fidler IJ . (1986). Experimental nude mouse model of human colorectal cancer liver metastases. J Natl Cancer Inst 77: 1303–1308.
  20. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS et al. (2009). Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69: 4116–4124. · DOI · Paper page
  21. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z et al. (2007). Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8: R76. · DOI · Paper page
  22. Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J . (1999). Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 56: 67–78. · doi:10.1023/a:1006285726561
  23. Kemperman H, Driessens MH, La Riviere G, Meijne AM, Roos E . (1995). Adhesion mechanisms in liver metastasis formation. Cancer Surv 24: 67–79.
  24. Kim TH, Huh JH, Lee S, Kang H, Kim GI, An HJ . (2008). Downregulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology 53: 48–55. · doi:10.1111/j.1365-2559.2008.03052.x
  25. Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T et al. (2007). Selective upregulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res 27: 3729–3734.
  26. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E et al. (2003). Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22: 2021–2033. · DOI · Paper page
  27. Kominsky SL, Vali M, Korz D, Gabig TG, Weitzman SA, Argani P et al. (2004). Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 164: 1627–1633. · DOI · Paper page
  28. Kramer F, White K, Kubbies M, Swisshelm K, Weber BH . (2000). Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum Genet 107: 249–256. · DOI · Paper page
  29. Kuhn S, Koch M, Nubel T, Ladwein M, Antolovic D, Klingbeil P et al. (2007). A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res 5: 553–567. · DOI · Paper page
  30. Kulka J, Szasz AM, Nemeth Z, Madaras L, Schaff Z, Molnar IA et al. (2009). Expression of tight junction protein claudin-4 in basal-like breast carcinomas. Pathol Oncol Res 15: 59–64. · doi:10.1007/s12253-008-9089-x
  31. Lanigan F, McKiernan E, Brennan DJ, Hegarty S, Millikan RC, McBryan J et al. (2009). Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer 124: 2088–2097. · DOI
  32. Lazo PA . (2007). Functional implications of tetraspanin proteins in cancer biology. Cancer Sci 98: 1666–1677. · DOI
  33. Magro G, Fraggetta F, Travali S, Lanzafame S . (1997). Immunohistochemical expression and distribution of alpha2beta1, alpha6beta1, alpha5beta1 integrins and their extracellular ligands, type IV collagen, laminin and fibronectin in palmar fibromatosis. Gen Diagn Pathol 143: 203–208.
  34. Martin TA, Jiang WG . (2009). Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 1788: 872–891. · DOI · Paper page
  35. Martin TA, Watkins G, Mansel RE, Jiang WG . (2004). Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer 40: 2717–2725. · DOI
  36. Mima S, Takehara M, Takada H, Nishimura T, Hoshino T, Mizushima T . (2008). NSAIDs suppress the expression of claudin-2 to promote invasion activity of cancer cells. Carcinogenesis 29: 1994–2000. · doi:10.1093/carcin/bgn134
  37. Morin PJ . (2005). Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65: 9603–9606. · DOI · Paper page
  38. Mourskaia AA, Dong Z, Ng S, Banville M, Zwaagstra JC, O'Connor-McCourt MD . et al. (2009). Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone. Oncogene 28: 1005–1015. · DOI
  39. Naik MU, Naik TU, Suckow AT, Duncan MK, Naik UP . (2008). Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res 68: 2194–2203. · DOI
  40. Northey JJ, Chmielecki J, Ngan E, Russo C, Annis MG, Muller WJ et al. (2008). Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion. Mol Cell Biol 28: 3162–3176. · DOI
  41. Osanai M, Murata M, Chiba H, Kojima T, Sawada N . (2007). Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells. Cancer Sci 98: 1557–1562. · DOI
  42. Osanai M, Murata M, Nishikiori N, Chiba H, Kojima T, Sawada N . (2006). Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res 66: 9125–9133. · DOI
  43. Penas PF, Garcia-Diez A, Sanchez-Madrid F, Yanez-Mo M . (2000). Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration. J Invest Dermatol 114: 1126–1135. · DOI
  44. Pentheroudakis G, Fountzilas G, Bafaloukos D, Koutsoukou V, Pectasides D, Skarlos D et al. (2005). Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Breast Cancer Res Treat 97: 237–244. · DOI
  45. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI et al. (2010). Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68. · DOI · Paper page
  46. Rose AA, Pepin F, Russo C, Abou Khalil JE, Hallett M, Siegel PM . (2007). Osteoactivin promotes breast cancer metastasis to bone. Mol Cancer Res 5: 1001–1014. · DOI · Paper page
  47. Rosenow F, Ossig R, Thormeyer D, Gasmann P, Schluter K, Brunner G et al. (2008). Integrins as antimetastatic targets of RGD-independent snake venom components in liver metastasis [corrected]. Neoplasia 10: 168–176. · DOI
  48. Sauer T, Pedersen MK, Ebeltoft K, Naess O . (2005). Reduced expression of claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 16: 193–198. · DOI
  49. Schluter K, Gassmann P, Enns A, Korb T, Hemping-Bovenkerk A, Holzen J et al. (2006). Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am J Pathol 169: 1064–1073. · DOI
  50. Selzner M, Morse MA, Vredenburgh JJ, Meyers WC, Clavien PA . (2000). Liver metastases from breast cancer: long-term survival after curative resection. Surgery 127: 383–389. · DOI · Paper page
  51. Soini Y . (2004). Claudins 2, 3, 4, and 5 in Paget′s disease and breast carcinoma. Hum Pathol 35: 1531–1536. · doi:10.1016/j.humpath.2004.09.015
  52. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J et al. (2010). Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 107: 15449–15454. · DOI · Paper page
  53. Thakur A, Sun Y, Bollig A, Wu J, Biliran H, Banerjee S et al. (2008). Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells. Clin Cancer Res 14: 4427–4436. · DOI
  54. Tiwari-Woodruff SK, Buznikov AG, Vu TQ, Micevych PE, Chen K, Kornblum HI et al. (2001). OSP/claudin-11 forms a complex with a novel member of the tetraspanin super family and beta1 integrin and regulates proliferation and migration of oligodendrocytes. J Cell Biol 153: 295–305. · DOI · Paper page
  55. Tokes AM, Kulka J, Paku S, Mathe M, Paska C, Lodi C et al. (2005). The expression of five different claudins in invasive breast carcinomas: comparison of pT1pN1 and pT1pN0 tumors. Pathol Res Pract 201: 537–544. · DOI
  56. Turksen K, Troy TC . (2004). Barriers built on claudins. J Cell Sci 117: 2435–2447. · DOI · Paper page
  57. Ugnat AM, Xie L, Morriss J, Semenciw R, Mao Y . (2004). Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer 90: 1138–1143. · doi:10.1038/sj.bjc.6601662
  58. Ura H, Denno R, Hirata K, Yamaguchi K, Yasoshima T . (1998). Separate functions of alpha2beta1 and alpha3beta1 integrins in the metastatic process of human gastric carcinoma. Surg Today 28: 1001–1006. · DOI
  59. Wisse E, Jacobs F, Topal B, Frederik P, De Geest B . (2008). The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Ther 15: 1193–1199. · DOI · Paper page
  60. Yanez-Mo M, Tejedor R, Rousselle P, Sanchez -Madrid F . (2001). Tetraspanins in intercellular adhesion of polarized epithelial cells: spatial and functional relationship to integrins and cadherins. J Cell Sci 114: 577–587. · DOI
  61. Yokomori H . (2008). New insights into the dynamics of sinusoidal endothelial fenestrae in liver sinusoidal endothelial cells. Med Mol Morphol 41: 1–4. · doi:10.1007/s00795-007-0390-7
  62. Yoshimura K, Meckel KF, Laird LS, Chia CY, Park JJ, Olino KL et al. (2009). Integrin alpha2 mediates selective metastasis to the liver. Cancer Res 69: 7320–7328. · doi:10.1158/0008-5472.can-09-0315

Cited by

See all 163

Metadata

Authors
Tabariès, S., Dong, Z., Annis, M. G., Omeroglu, A., Pepin, F., Ouellet, V, Russo, C., Hassanain, M., Metrakos, P., Diaz, Z., Basik, M., Bertos, N., Park, M., Guettier, C., Adam, R., Hallett, M., & Siegel, P. M.
Venue
Oncogene
Published
2010-11-15
Volume
30
Issue
11
Pages
1318-1328
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2023755204
Cited by
163
References
2
FWCI
5.47
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. https://app.cochat.ai/papers/10.1038/onc.2010.518
The paper
Tabariès, S., Dong, Z., Annis, M. G., Omeroglu, A., Pepin, F., Ouellet, V, Russo, C., Hassanain, M., Metrakos, P., Diaz, Z., Basik, M., Bertos, N., Park, M., Guettier, C., Adam, R., Hallett, M., & Siegel, P. M. (2011). Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene. https://doi.org/10.1038/onc.2010.518

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.